| 3821 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
Internal Medicine |
2018 |
| 3822 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
Internal Medicine |
2018 |
| 3823 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
Department of Pharmacology |
2018 |
| 3824 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
Department of Pharmacology |
2018 |
| 3825 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
Department of Microbiology and Immunology |
2018 |
| 3826 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
Department of Biochemistry |
2018 |
| 3827 |
الخلايا السرطانية الدوارة (CTCs) كمؤشر حيوي في حالات سرطان الثدي الغير منتشر |
Department of Rheumatology ,Rehabilitation & physical medicine |
2018 |
| 3828 |
الخلايا السرطانية الدوارة (CTCs) كمؤشر حيوي في حالات سرطان الثدي الغير منتشر |
Department of Rheumatology ,Rehabilitation & physical medicine |
2018 |
| 3829 |
الخلايا السرطانية الدوارة (CTCs) كمؤشر حيوي في حالات سرطان الثدي الغير منتشر |
Department of Rheumatology ,Rehabilitation & physical medicine |
2018 |
| 3830 |
Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder |
Department of Pathology |
2017/10/18 |
Do you have any questions? 
